Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-5704/SI-613) for treatment of osteoarthritis: 1-year follow-up

BACKGROUND: We evaluated the 1-year safety and efficacy of diclofenac etalhyaluronate (DF-HA), a diclofenac-conjugated hyaluronate, in patients with osteoarthritis (OA). METHODS: In this multi-centre, open-label, noncomparative phase 3 study in Japan, patients with a diagnosis of knee, shoulder, elb...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Yoshihiro, Kano, Kazuyuki, Osato, Taiki, Seo, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923517/
https://www.ncbi.nlm.nih.gov/pubmed/33648473
http://dx.doi.org/10.1186/s12891-021-04108-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923517/
https://www.ncbi.nlm.nih.gov/pubmed/33648473
http://dx.doi.org/10.1186/s12891-021-04108-9

Ejemplares similares